Ftse Mib
33.800,19
-1,45%
DAX
17.932,17
-1,10%
S&P 500
5.035,69
-1,57%
NASDAQ Composite
15.657,82
-2,04%
Bitcoin
60.060,86
-5,92%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Palisade Bio Inc (PALI) Palisade Bio Inc (PALI) Notizie

Palisade Bio Inc

PALI
6,03
-0,15 (-2,43%)
Dopo l'orario di negoziazione
Ultimo aggiornamento: 22:54:19
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
23/4/202414:30GLOBEPalisade Bio Enters into Strategic Collaboration with Strand..
16/4/202414:30GLOBEPalisade Bio Successfully Demonstrates Bioactivation of..
11/4/202415:15GLOBEPalisade Bio to Participate in the Virtual Investor Lunch..
10/4/202414:15GLOBEPalisade Bio Presents Development Overview of PALI-2108 at..
03/4/202423:30GLOBEPalisade Bio Announces 1-for-15 Reverse Stock Split
27/3/202413:00GLOBEPalisade Bio Reports Year End 2023 Financial Results and..
06/3/202422:35EDGAR2Form 8-K - Current report
15/2/202414:35GLOBEPalisade Bio to Present at Digestive Disease Week (DDW) 2024
14/2/202420:54EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
14/2/202402:10EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
13/2/202422:38EDGAR2Form 8-K - Current report
13/2/202421:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/2/202421:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/2/202421:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/2/202421:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/2/202420:51EDGAR2Form D - Notice of Exempt Offering of Securities
13/2/202414:35GLOBEPalisade Bio Provides Corporate Update and Reiterates..
09/2/202422:03EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
08/2/202422:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/2/202422:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/2/202420:40GLOBECorrection Notice of Palisade Bio’s Press Release Announcing..
08/2/202414:05GLOBEPalisade Bio Announces Formation of Clinical Advisory Board..
07/2/202414:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/2/202423:01EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
06/2/202423:00EDGAR2Form DEF 14A - Other definitive proxy statements
06/2/202416:29EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
01/2/202414:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/2/202414:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/2/202412:14EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
01/2/202412:14EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
01/2/202412:14EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
01/2/202412:02EDGAR2Form 8-K - Current report
30/1/202415:25GLOBEPalisade Bio Announces Exercise of Previously Issued..
29/1/202414:30EDGAR2Form 8-K - Current report
29/1/202414:05GLOBEPalisade Bio Announces Positive Preclinical Data of Lead..
26/1/202422:45EDGAR2Form PRE 14A - Other preliminary proxy statements
26/1/202422:00EDGAR2Form RW - Registration Withdrawal Request
09/1/202414:00GLOBEPalisade Bio Selected for Poster Presentation at the 2024..
05/1/202422:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/12/202322:01EDGAR2Form S-1 - General form for registration of securities under..
28/12/202314:00GLOBEPalisade Bio Announces Receipt of Second Milestone Payment..
19/12/202323:57EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/11/202322:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/11/202322:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/11/202322:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/11/202322:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/11/202322:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/11/202322:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/11/202322:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/11/202314:05GLOBEPalisade Bio Reports Third Quarter 2023 Financial Results..
Apertura: 5,94 Min: 5,81 Max: 6,31
Chiusura: 6,18

La tua Cronologia

NASDAQ
PALI
Palisade Bio
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network